De La Mora v. Saul

CourtDistrict Court, N.D. Illinois
DecidedMay 10, 2022
Docket1:19-cv-05247
StatusUnknown

This text of De La Mora v. Saul (De La Mora v. Saul) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
De La Mora v. Saul, (N.D. Ill. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

PATRICIA D., ) ) Plaintiff, ) ) No. 19 C 5247 v. ) ) Magistrate Judge Gabriel A. Fuentes KILOLO KIJAKAZI, Acting ) Commissioner of Social Security,1 ) ) Defendant. )

MEMORANDUM OPINION AND ORDER2

Plaintiff Patricia D.3 was born on December 31, 1971. She alleges that she has been disabled since her alleged onset date (“AOD”) of January 16, 2016, because of weakness in her left arm and hand, tingling in her feet, numbness in her legs, brain fog, autoimmune disease of unknown type, severe fatigue, forgetfulness, and depression. (R. 184, 205.) She applied for

1 The Court substitutes Kilolo Kijakazi for her predecessor, Andrew Saul, as the proper defendant in this action pursuant to Federal Rule of Civil Procedure 25(d) (a public officer’s successor is automatically substituted as a party).

2 On October 16, 2019, by consent of the parties and pursuant to 28 U.S.C. § 636(c) and Local Rule 73.1, this case was assigned to a United States Magistrate Judge for all proceedings, including entry of final judgment. (D.E. 8.)

3 The Court in this opinion is referring to Plaintiff by her first name and first initial of her last name in compliance with Internal Operating Procedure No. 22 of this Court. IOP 22 presumably is intended to protect the privacy of plaintiffs who bring matters in this Court seeking judicial review under the Social Security Act. The Court notes that suppressing the names of litigants is an extraordinary step ordinarily reserved for protecting the identities of children, sexual assault victims, and other particularly vulnerable parties. Doe v. Vill. of Deerfield, 819 F.3d 372, 377 (7th Cir. 2016). Allowing a litigant to proceed anonymously “runs contrary to the rights of the public to have open judicial proceedings and to know who is using court facilities and procedures funded by public taxes.” Id. A party wishing to proceed anonymously “must demonstrate ‘exceptional circumstances’ that outweigh both the public policy in favor of identified parties and the prejudice to the opposing party that would result from anonymity.” Id., citing Doe v. Blue Cross & Blue Shield United of Wis., 112 F.3d 869, 872 (7th Cir. 1997). Under IOP 22, both parties are absolved of making such a showing, and it is not clear whether any party could make that showing in this matter. In any event, the Court is abiding by IOP 22 subject to the Court’s concerns as stated. Disability Insurance Benefits (“DIB”) in June 2016 and her date last insured (“DLI”) was December 31, 2020. (R. 204.) On September 27, 2018, an Administrative Law Judge (“ALJ”) issued an opinion finding Plaintiff not disabled. (R. 17-42.) The Appeals Council denied review (R. 1-7), making the ALJ’s decision the final decision of the Commissioner. Butler v. Kijakazi, 4

F.4th 498, 500 (7th Cir. 2021). Before the Court are Plaintiff’s motion seeking remand of that decision (D.E. 12) and the Commissioner’s cross-motion to affirm. (D.E. 24.) I. Administrative Record A. Medical Evidence In January 2015, Plaintiff visited Dr. Kathryn Kiehn, M.D., a rheumatologist, for medication management and because of complaints of tingling in her left hand and memory issues. (R. 381-82.) Dr. Kiehn noted that despite Plaintiff’s positive ANA test,4 her symptoms – tingling and numbness in her hands and feet causing difficulty holding items, fatigue and memory issues – were of an unknown cause and did not fit into typical signs of connective tissue disease, despite her high ANA. (Id.) On examination, Plaintiff had full range of motion (“ROM”) in her

extremities, normal gait, and no tender points. (R. 383.) Dr. Kiehn prescribed amitriptyline, a medication generally used to treat nerve pain, and then increased the dose in March 2015 after Plaintiff reported less stiffness and fewer episodes of tingling and weakness in her hands. (R. 377.) Plaintiff continued taking amitriptyline after appointments in May and August 2015; in November 2015 she reported increased balance problems and underwent a brain MRI and bloodwork. (R.

4 A positive ANA test means that antinuclear antibodies have been detected in a patient’s blood, which suggests that “the immune system has launched a misdirected attack on [their] own tissue.” Positive ANA could be indication of a connective tissue disease such as lupus or rheumatoid arthritis, although more testing would be needed to confirm the diagnosis. https://www.mayoclinic.org/tests-procedures/ana- test/about/pac-20385204. Visited on April 11, 2022. 366-67.) Her ROM continued to be normal at each appointment, and she had good muscle tone. (Id.) The next treatment notes from Dr. Kiehn are dated January 22, 2016, just after Plaintiff’s AOD. She complained of overall stiffness and worsening of the numbness in her hands, balance

issues, and increased fatigue and memory issues. (R. 361.) Testing for suspected systemic lupus erythematosus (“SLE”) was negative and her brain/neck MRI from November was unremarkable for neurological changes but showed mild-to-moderate multilevel degenerative changes in her cervical spine with stenosis but no cord compression. (R. 362, 464-65.) Plaintiff thereafter underwent cervical fusion disc surgery in February 2016. (R. 465, 750.) She visited Dr. Kiehn again in April 2016 complaining of continued body numbness and tingling, fatigue and inflammatory arthritis but noted that she was now able to hold a glass of water; the doctor again increased Plaintiff’s dose of amitriptyline. (R. 358.) In May 2016, Plaintiff complained of joint pain “all over” and bilateral foot tingling and numbness and was still ANA positive. (R. 352.) Her dosage of amitriptyline was reduced so that she could begin a course of methotrexate, an

immunosuppressant. (Id.) On examination, all of her extremity joints, her back, and her neck were normal and had full ROM with no swelling except for bilateral thickening in one ankle joint; she had multiple diffuse tender points. (R. 355.) In July 2016, Dr. Kiehn identified numerous tender points although Plaintiff also had normal ROM and muscle tone; she reported improvement of her symptoms with the methotrexate. (R. 348-51.) Also in July, Plaintiff saw neurologist Ian Katznelson, M.D. as a follow up after her cervical spine surgery. (R. 647.) Dr. Katznelson noted that Plaintiff reported improved fine motor control in her left upper extremity and that she thought she might have become a bit more forgetful. (R. 647.) An MRI of her brain was unremarkable. (R. 670.) In September 2016, x-rays revealed degenerative disc disease (“DDD”) of the lumbar spine. (R. 571.) In October 2016, Plaintiff reported increased dizziness when climbing stairs and that she still had good and bad days;5 Dr. Kiehn found multiple diffuse tender points. (R. 633-35.) Plaintiff underwent a consultative physical examination in September 2016, at which

Debbie Weiss, M.D., opined that Plaintiff’s effort on testing was “fair-to-poor.” (R. 567.) Dr. Weiss’s overall clinical impression was that Plaintiff had multiple tender joints and trigger points from an unknown auto-immune disorder, decreased ROM in the cervical spine, lumbar spine, and shoulders, and impairment in the use of both hands. (R. 568.) During Plaintiff’s mini-mental status examination she demonstrated some short-term memory issues; Dr. Weiss noted that Plaintiff seemed to be “down” but not overly depressed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Norbert J. Skarbek v. Jo Anne B. Barnhart
390 F.3d 500 (Seventh Circuit, 2004)
Bradley Shideler v. Michael Astrue
688 F.3d 306 (Seventh Circuit, 2012)
Rebecca Pepper v. Carolyn W. Colvin
712 F.3d 351 (Seventh Circuit, 2013)
Denton v. Astrue
596 F.3d 419 (Seventh Circuit, 2010)
Simila v. Astrue
573 F.3d 503 (Seventh Circuit, 2009)
Schmidt v. Astrue
496 F.3d 833 (Seventh Circuit, 2007)
Elder v. Astrue
529 F.3d 408 (Seventh Circuit, 2008)
John Doe v. Village of Deerfield
819 F.3d 372 (Seventh Circuit, 2016)
Kim Stevenson v. Carolyn Colvin
654 F. App'x 848 (Seventh Circuit, 2016)
Gotoimoana Summers v. Nancy A. Berryhill
864 F.3d 523 (Seventh Circuit, 2017)
Ashley Gerstner v. Nancy A. Berryhill
879 F.3d 257 (Seventh Circuit, 2018)
Biestek v. Berryhill
587 U.S. 97 (Supreme Court, 2019)
Alice Gedatus v. Andrew Saul
994 F.3d 893 (Seventh Circuit, 2021)
Mike Butler v. Kilolo Kijakazi
4 F.4th 498 (Seventh Circuit, 2021)
Debra Prill v. Kilolo Kijakazi
23 F.4th 738 (Seventh Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
De La Mora v. Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/de-la-mora-v-saul-ilnd-2022.